HRGN · Harvard Apparatus Regenerative Technology, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“Because these resources are not expected to fund the Company's operations for at least 12 months from the date the financial statements are issued, substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Every disclosed holder of HRGN in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns HRGN
13F quarter Jun 30, 2022| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 13,383 | 0.08% |
| Insiders (Forms 3, 4, 5) | 1,332,930 | 7.58% |
| 13D/G-only blocks | 6,567,443 | 37.36% |
| Remaining | 9,666,988 | 54.99% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 17,580,744, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of HRGN
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
|
3,756,547 | ||
| 2 |
STELLARS CAPITAL PRIVATE I LIMITED
13D
CIK 2036048 · Unknown · Aug 26, 2024
unconfirmed, last confirmed Aug 26, 2024
|
2,113,784 | ||
| 3 |
|
1,332,930 | ||
| 4 |
Harvard Bioscience, Inc.
13G
CIK 1123494 · Unknown · Jan 9, 2024
Rule 13d-1(c), passive investor, unconfirmed, last confirmed Jan 9, 2024
|
697,112 | ||
| 5 |
GRACE & WHITE INC /NY
13F
CIK 903064 · Registered investment adviser · Jun 30, 2022
|
13,383 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.